Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120177) titled 'A Prognostic Study on Dexmedetomidine in the Treatment of Insomnia Patients and the Establishment of an Individualized Prediction Model' on March 10.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Changzhou No. 2 People's Hospital
Condition:
Chronic Insomnia
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-03-10
Target Sample Size: The dexmedetomidine group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=294348
Disclaimer: Curated by HT Syndication....